CBMG Recent News

Cellular Biomedicine Group Announces Updated Results From Phase I/IIa Clinical Trial for ReJoin(TM) Treatment of Knee Osteoarthritis (KOA) GlobeNewswire - Mon Feb 24, 10:15AM CST
Cellular Biomedicine Group to Present at New York Stem Cell Summit GlobeNewswire - Wed Feb 05, 6:24PM CST
Cellular Biomedicine Group Announces Appointment of New Chief Financial Officer and Board Secretary and New Audit Committee Chair GlobeNewswire - Fri Jan 03, 11:45AM CST
Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer PR Newswire - Fri Dec 13, 2:33PM CST
Cellular Biomedicine Group to Present "Expedited Development of Cellular Medicine" at Hong Kong Biotech Horizons Conference GlobeNewswire - Tue Nov 19, 12:05AM CST
Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting PR Newswire - Sat Nov 09, 4:55AM CST
Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting PR Newswire - Thu Nov 07, 1:45PM CST
Cellular Biomedicine Group Receives Approval for Phase IIb Clinical Trial of ReJoin(TM) for Treatment of Knee Osteoarthritis (KOA) PR Newswire - Tue Nov 05, 10:36AM CST
Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA) PR Newswire - Fri Nov 01, 9:01AM CDT
Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License PR Newswire - Wed Oct 30, 8:01AM CDT